chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US025040, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 74-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 23 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 32.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025039, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 32-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 31 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Confusional state, Hyperhidrosis, Loss of consciousness, Muscle twitching, Nausea
Clinical narrative: Initial unsolicited report received from a Nurse on 14 December 2015. This case involves a male patient whose age was reported as "18" who was vaccinated with a dose of MENACTRA (batch number- U5179AA, site of administration was not reported) intramuscularly and also received a dose of BOOSTRIX (batch number- 2729X, manufacturer GSK, route and site of administration were not reported), a dose of Hep A (batch number- F3J75, route and site of administration were not reported), a dose of Varicella (batch number- L026412, manufacturer Merck, route and site of administration were not reported) and a dose of HPV (batch number- L014415, route and site of administration were not reported) on 03 December 2015. The patient's medical history includes illness at time of vaccination, pre-existing physician diagnosed allergies, birth defects and medical conditions were reported as none. The patient's concomitant medications were not reported. On 03 December 2015, 30 seconds following the vaccination, the patient had experienced seizure like activity, twitching of arms and head, loss of consciousness (for 30 seconds) and confusion (for 10 minutes). The patient was pale, diaphoretic and nauseous. Laboratory data was reported as none. The patient's corrective treatment was not reported. On an unspecified date, the patient was recovered from the events within 10 minutes. Upon internal review the case was considered as serious because of important medical event seizure like phenomena/activity, loss of consciousness, twitching, postictal confusion, pale, diaphoresis, nausea. List of documents held by sender: none.
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Pallor, Seizure like phenomena
Clinical narrative: Initial unsolicited report received from a Nurse on 14 December 2015. This case involves a male patient whose age was reported as "18" who was vaccinated with a dose of MENACTRA (batch number- U5179AA, site of administration was not reported) intramuscularly and also received a dose of BOOSTRIX (batch number- 2729X, manufacturer GSK, route and site of administration were not reported), a dose of Hep A (batch number- F3J75, route and site of administration were not reported), a dose of Varicella (batch number- L026412, manufacturer Merck, route and site of administration were not reported) and a dose of HPV (batch number- L014415, route and site of administration were not reported) on 03 December 2015. The patient's medical history includes illness at time of vaccination, pre-existing physician diagnosed allergies, birth defects and medical conditions were reported as none. The patient's concomitant medications were not reported. On 03 December 2015, 30 seconds following the vaccination, the patient had experienced seizure like activity, twitching of arms and head, loss of consciousness (for 30 seconds) and confusion (for 10 minutes). The patient was pale, diaphoretic and nauseous. Laboratory data was reported as none. The patient's corrective treatment was not reported. On an unspecified date, the patient was recovered from the events within 10 minutes. Upon internal review the case was considered as serious because of important medical event seizure like phenomena/activity, loss of consciousness, twitching, postictal confusion, pale, diaphoresis, nausea. List of documents held by sender: none.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025038, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 41-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 26 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2015 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 10.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: VIIth nerve paralysis
Clinical narrative: Initial unsolicited report received from a nurse on 30 July 2015. A ten years old female patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of ADACEL (batch number- C4774AA, exp. date: 15 July 2017) in left deltoid and an intramuscular dose of MENACTRA (batch number- U5155BA, exp. date: 13 January 2017) in right deltoid on 22 July 2015. The patient did not have any known allergies. Illness at the time of vaccination was reported as none. On 27 July 2015, five days after vaccination, the patient experienced Bell's Palsy. The patient required emergency room/doctor visit. Laboratory investigations were reported as none. Corrective treatments included Amoxicillin and Prednisone. At the time of this report, the patient had not recovered from the event. Upon medical review, the case was considered as serious due to important medical event: Bell's Palsy. Documents held by sender: none. Follow-up information received from physician on 24 August 2015. It was reported that other vaccination within 4 weeks prior to vaccination, illness at the time of vaccination was reported as none and pre-existing physician diagnosed allergies, birth defects and medical conditions was reported as mild intermittent asthma. The patient was vaccinated at private doctor's office/hospital and was purchased with private funds. Corrective treatments also included VALTREX. The patient's mother reported that the patient was recovering with some symptoms of Palsy but improvement and was expected to recover over next few weeks.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025037, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 72-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025036, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 33-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 31 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 85.0
Sex: M
Vaccine: VARZOS
Symptoms: Acne, Burning sensation, Eyelid oedema, Pruritus, Skin warm
Clinical narrative: PATIENT REPORTED SWOLLEN EYE UNABLE TO OPEN FULLY, PIMPLES ON FOREHEAD, FOREHEAD SKIN ITCHY, HOT TO THE TOUCH, BURNING.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Dizziness, Headache, Mood swings, Nausea
Clinical narrative: Nausea, mood swings, weight gain, pain in teeth, dizziness, headache, joint pain.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Toothache, Weight increased
Clinical narrative: Nausea, mood swings, weight gain, pain in teeth, dizziness, headache, joint pain.
Age: 1.25
Sex: M
Vaccine: VARCEL
Symptoms: Abasia, Crying, Emotional distress, Feeling abnormal, Inability to crawl
Clinical narrative: Paralyzed from waist down. Couldn't walk or crawl. Screaming crying after vaccination for a few days. Sleeping in a backwards C position. Irritable. Upset. Lots of crying and spacing out.
Age: 1.25
Sex: M
Vaccine: VARCEL
Symptoms: Irritability, Opisthotonus, Paralysis, Screaming, X-ray of pelvis and hip
Clinical narrative: Paralyzed from waist down. Couldn't walk or crawl. Screaming crying after vaccination for a few days. Sleeping in a backwards C position. Irritable. Upset. Lots of crying and spacing out.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, Swelling at injection site.  Hot to touch.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025031, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 84-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 17 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursions began on 16 Oct 2014 and the temperature was in between 46 tot 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 74.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025030, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 74-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 23 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025029, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 84-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 31 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 90.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025085, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 90-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 24 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025084, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 81-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 03 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 19.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025083, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 19-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN, (batch number: 145701) intramuscularly at a dose of 0.5 ml on 23 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug).
Age: 13.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025081, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 13-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 06 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025080, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 15-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 06 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Rash pruritic, Urticaria
Clinical narrative: At OV today, pt reports that after she left office on day of vacc, at 1/2 hour, started with "hives/itchy bumps" at elbow. She did not call us. Was on CLARITIN, used HCT cream, resolved on its own.
Sex: U
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US0255051 is an initial spontaneous report received from a pharmacist on 11 Dec 2014. This report refers to a patient of unknown age and gender. Past medical history and concomitant medications were not reported. On 10 Dec 2014, the patient was vaccinated with FLUVIRIN (batch number: 1414101) intramuscularly, that had been at 32 F for up to 3 days and vaccine did not appear frozen. No adverse event was reported following this administration error.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025088, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 40-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 23 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 14.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025087, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 14-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 18 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025086, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 42-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 1455701) intramuscularly at a dose of 0.5 ml on 10 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025104 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 69 year old female patient. Medical history and concomitant medication were not reported. She was vaccinate with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 19 Nov 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Inflammation, Musculoskeletal pain
Clinical narrative: Initial unsolicited report received from a pharmacist in the United States on 08 December 2015. This case involves 68-years-old female patient who was vaccinated with a dose of Fluzone HD batch number, dose in series were unknown and dose, expiry date were not reported) intramuscularly in right deltoid on 04 December 2015. Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were reported as unknown. On an unknown date, following the vaccination, the patient had developed internal radiating pain to the shoulder. It was reported that no injection site redness, swelling or pain. The patient's laboratory data corrective treatment was not reported. The patient was not recovered from the event. Follow-up information received from a pharmacist on 11 January 2016. Lot number and expiry date of Fluzone HD was reported as UI1513AA and 12 June 2016. Patient was vaccinated with the second dose of vaccine at pharmacy. Patient was previously vaccinated with a first dose of Fluzone HD on an unspecified date. Patient did not experience any other vaccinations four weeks prior to the current vaccination. On an unspecified date, patient experienced pain and inflammation in her shoulder. It was stated that even one week post vaccination after usage of Ibuprofen regularly for a week, she went to physician who prescribed a 6 day regimen of a Medrol dose pack for the pain and inflammation in her shoulder and when that regimen was finished patient started Cyclobenzaprine, a muscle relaxant for a few days until the pain was resolved and was assisted by an accopantonist. On an unspecified date, patient recovered from the event pain and outcome of the event inflammation was not reported. List of documents held by sender: none.
Age: 14.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025114, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 14-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 10 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 75.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025113, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 75-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 29 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event report following this medication error.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 40-year-old female patients. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml 19 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 40.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025111, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 40-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 19 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025110, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 53-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 29 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursions began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025109, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 57-year-old female. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025107, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 80-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscular at a dose of 0.5 ml on 24 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025106, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 62-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 10 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 82.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025105, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 82-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025103 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 75 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 04 Nov 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46049 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025102 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 53 year old male patient. Medical history and concomitant medication were not reported. He was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 29 Oct 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025024, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 73-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 26 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursions began on 16 Oct 2014 and the temperature was between 46 6o 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 78.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US025025, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 78-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reporting following this medication error.
Age: 83.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025026, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 83-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 12 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025027, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 30-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 31 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025028, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 45-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period o 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 88.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025090, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 88-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 10 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025091, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 57-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025092, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 63-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 52.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025093, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 52-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 24 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025094, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 60-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 10 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025095, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 64-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 27 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025096, is an initial spontaneous report received from a nurse on 09 Dec 1014. This report refers to a 57 year old male patient. Medical history and concomitant medication were not reported. He was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. Nurse reported that patient received FLUVIRIN that was at degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025097, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 32 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 04 Nov 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: C/O ITCHING IN RT ANTICUBITAL, THEN LEFT WITH ERYTHEMA, HIVES, WHEAL AND ITCHINESS ON BACK AND FRONT OF TORSO.  NO DIFFICULTY BREATHING.  50 MG BENADRYL GIVEN IM, SYMPTOMS SUBSIDED IN 20 MINUTES.
Age: 4.0
Sex: M
Vaccine: DTAP, FLUX, IPV, DTAP, FLUX, IPV
Symptoms: Rash, Swelling, Urticaria
Clinical narrative: Rash, hives, swelling (all very severe requiring medication).
Age: 1.0
Sex: F
Vaccine: PNC13, VARCEL
Symptoms: Erythema, Rash vesicular, Varicella virus test positive
Clinical narrative: 5-6 vesicular lesions-2 on back, one on head, on face, one on leg.  One lesion on back was large and surrounded by erythema.
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache
Clinical narrative: Patient states they have had a headache ever since receiving the vaccine.
Age: 54.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Redness, swelling, hotness in the area of vaccine injection.  Fever (subjective, unmeasured).
Age: 86.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site swelling
Clinical narrative: Severe swelling in left shoulder to elbow for one and a half weeks.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Activities of daily living impaired, Blood glucose normal, Dry eye, Eyelid oedema, Fatigue
Clinical narrative: On November 7, 2015 I woke up with puffy eyelids, blurred vision and extreme photosensitivity.  I was also very tired.  I was evaluated by my doctor who was unsure if the Prevnar 13 vaccine was the reason for the symptoms.  He ordered labwork which essentially was normal.  He placed me on cortisone/antibiotic eyedrops as well as a Cortisone taper dose for 9 days.  I saw my optometrist for an eye check to see if he could determine the cause for the light sensitivity; he said my exam had not changed from August but thought there may be something systemic as the cause.  On November 30 I again saw my family doctor who referred me to my ophthalmologist.  I saw him on Dec. 7 and he said I had dry eyes and put me on drops.  I had never had dry eyes prior to this event.  Symptoms persisted so my doctor ordered an MRI of my brain which did not reveal any abnormality.  I am told I may have Sjogren's syndrome and it will take time for symptoms to improve. My activities of daily living are very impacted.  I know time has passed since the vaccine but I feel there is a direct correlation to the Prevnar 13 vaccine.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Nuclear magnetic resonance imaging brain abnormal, Photosensitivity reaction, Sjogren's syndrome, Vision blurred
Clinical narrative: On November 7, 2015 I woke up with puffy eyelids, blurred vision and extreme photosensitivity.  I was also very tired.  I was evaluated by my doctor who was unsure if the Prevnar 13 vaccine was the reason for the symptoms.  He ordered labwork which essentially was normal.  He placed me on cortisone/antibiotic eyedrops as well as a Cortisone taper dose for 9 days.  I saw my optometrist for an eye check to see if he could determine the cause for the light sensitivity; he said my exam had not changed from August but thought there may be something systemic as the cause.  On November 30 I again saw my family doctor who referred me to my ophthalmologist.  I saw him on Dec. 7 and he said I had dry eyes and put me on drops.  I had never had dry eyes prior to this event.  Symptoms persisted so my doctor ordered an MRI of my brain which did not reveal any abnormality.  I am told I may have Sjogren's syndrome and it will take time for symptoms to improve. My activities of daily living are very impacted.  I know time has passed since the vaccine but I feel there is a direct correlation to the Prevnar 13 vaccine.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025099, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 32 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 27 Oct 20214. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025100, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 64 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 24 Oct 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025101, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 62 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025098, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 72 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 27 Oct 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Age: 80.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025065, is an initial spontaneous report received from nurse on 09 Dec 2014. This report refers to an 80 year old male patient. Medical history and concomitant medication were not reported. He was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 05 Nov 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.